Page last updated: 2024-11-08

primycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

primycin: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID418027
MeSH IDM0053415

Synonyms (3)

Synonym
primycin
(5-(19-(alpha-d-arabinofuranosyloxy)-35-butyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxooxacyclohexatriaconta-4,20-dien-2-yl)-4-hydroxyhexyl)guanidine
DTXSID101023587

Research Excerpts

Overview

Primycin is a large 36-membered non-polyene macrolide lactone exclusively produced by Saccharomonospora azurea. Primycin-sulphate is a highly effective compound against Gram (G) positive bacteria.

ExcerptReferenceRelevance
"Primycin is a large 36-membered non-polyene macrolide lactone exclusively produced by Saccharomonospora azurea."( Structural and functional comparison of Saccharomonospora azurea strains in terms of primycin producing ability.
Csepregi, K; Fekete, C; Juhász, Á; Kerepesi, I; Kovács, M; Kovács-Valasek, A; Pénzes-Hűvös, Á; Seffer, D, 2020
)
1.5
"Primycin-sulphate is a highly effective compound against Gram (G) positive bacteria. "( Toxicology studies of primycin-sulphate using a three-dimensional (3D) in vitro human liver aggregate model.
Bovári-Biri, J; Fekete, C; Kvell, K; Mahmud Abdelwahab, EM; Miskei, G; Pénzes, Á; Péteri, ZA; Pongrácz, JE; Rapp, J, 2017
)
2.21
"Primycin is a macrolide antibiotic complex produced in microbiological fermentation processes. "( Biological and chemical detections in adsorbent layer for monitoring microbial production of primycin.
Erdélyi, B; Kónya, A; Máté, G; Szabó, A; Széll, V, 2007
)
2

Treatment

ExcerptReferenceRelevance
"Primycin treatment was shown to evoke a dose-dependent decrease of the depolarization induced by 20 mM K+-Ringer."( Effect of primycin on some electric properties of the frog skeletal muscle.
Gesztelyi, I; Kónya, L; Kövér, A, 1980
)
1.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (39)

TimeframeStudies, This Drug (%)All Drugs %
pre-199025 (64.10)18.7374
1990's1 (2.56)18.2507
2000's1 (2.56)29.6817
2010's11 (28.21)24.3611
2020's1 (2.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.01 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.56%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (2.56%)4.05%
Observational0 (0.00%)0.25%
Other37 (94.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]